Blood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.

Similar documents
Policy for Patient Identification. Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead:

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Competency Framework for the Administration of all Blood Products

A Guide To Safe Blood Transfusion Practice

Policy for the Reporting and Management of Incidents Including Serious Incidents. Version Number: 006

REPORT OF BLOOD SAFETY REVIEW

JOB DESCRIPTION. Specialist Practitioner of Transfusion for Shrewsbury, Telford and surrounding community hospitals. Grade:- Band 7 Line Manager:-

Trust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:

POLICY FOR THE TRANSFUSION OF BLOOD AND BLOOD COMPONENTS

Sample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Trust Policy for Blood Transfusion

NON-MEDICAL PRESCRIBING POLICY

Right Patient Right Blood Monitoring Compliance Reference Number:

HYWEL DDA LOCAL HEALTH BOARD. Transfusion Policy. Completed Action: Addresses all aspects of transfusion with blood and blood components

Irradiated blood products - Pathway for requesting To provide healthcare professionals with clear guidance on the use of irradiated blood products.

Health Service Circular

Blood / Blood Products Transfusion A Liquid Transplant

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

Changes in practice and organisation surrounding blood transfusion in NHS trusts in England

PROGRESS WITH NPSA ALERT IMPLEMENTATION

Implementation Guide Single Unit Transfusion Policy

Medicines Management Strategy

Lessons for Transfusion Laboratory Staff. from the 2007 SHOT Report SHOT SERIOUS HAZARDS OF TRANSFUSION

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

SFHGEN57 - SQA Code HD36 04 Collect blood / blood products from storage for transfusion

Medicines Policy v1.0

Patient Blood Management An Overview. Denise Watson Patient Blood Management Practitioner 11 th January, 2016

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY

Prevention and Treatment of Venous Thromboembolism (VTE) Policy

2015 Survey of Patient Blood Management (PBM)

Guidance for MRC units on HTA licence applications for storage of human samples for research purposes

2015 Survey of Patient Blood Management (PBM)

BED RAILS: MANAGEMENT AND SAFE USE POLICY MAY This policy supersedes all previous policies relating Bed Rails

Royal Wolverhampton Hospitals NHS Trust. Job Description Haematology

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Central Alert System (CAS) Policy and Procedure

Sharps Policy Safe Use and Disposal

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

BLOOD TRANSFUSION POLICY

SFHCHS25 - SQA Code HC9M 04 Carry out blood collection from fixed or central lines

Reducing Medication Errors: National Update

POL:02:UP:001:07:NIBT PAGE 1 of 6 ISSUE DATE: 12 DECEMBER 2014 EFFECTIVE DATE: 9 JANUARY 2015

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016

Version: 5 Date Issued: 24 October 2017 Review Date: 24 October 2020 Document Type: Policy. Sharps Safety Policy Quick Reference Guide

POL:08:LP:003:03:NIBT PAGE : 1 of 5. Document Title: NIBTS POLICY FOR RETURN AND RE-ISSUE OF BLOOD AND BLOOD COMPONENTS

Hepatitis B Immunisation procedure SOP

Safety Reporting in Clinical Research Policy Final Version 4.0

Control of Artificial Optical Radiation at Work Regulations 2010 Contributes to CCQ Core Outcome 12

Policy Checklist. Working Group: Administration of Infusion of Intravenous Fluids & Medicines in Neonates (Chairperson: Dr Hogan) YES

UK TRANSFUSION LABORATORY COLLABORATIVE

Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation

Improving compliance with oral methotrexate guidelines. Action for the NHS

Laboratory Request Form Completion and Specimen Labelling Reference Number:

Babylon Healthcare Services

Consent for Blood Transfusion

NHS Fife. Local Report ~ July Blood Transfusion

CAUTION: Refer to the Document Library for the most recent version of this policy. Blood Transfusion Policy. Pathology Transfusion.

Blood Products Policy

PATIENT IDENTIFICATION POLICY

Consent for Blood Transfusion and Patient Information. Alister Jones PBM Practitioner, NHSBT Mothers, Babies and Blood. January 27 th 2016

VELINDRE NHS TRUST. Trust Procedure PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

ORAL ANTI-CANCER THERAPY POLICY

Document Details Clinical Audit Policy

Date 4 th September 2015 Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate Director of Quality Laura Rowe, Compliance Manager

Reconciliation of Medicines on Admission to Hospital

POLICY FOR TAKING BLOOD CULTURES

Policies, Procedures, Guidelines and Protocols

Clinical Standards ~ September Blood Transfusion

NHSLA Risk Management Standards

Competency Assessment for Non Medical Prescribing of Blood and Blood Components

Moving and Handling Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

Burton Hospitals NHS Foundation Trust. On: 25 January Review Date: December Corporate / Directorate. Department Responsible for Review:

Standard Operating Procedure Research Governance

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Newborn Hearing Screening Programme Policy

Guidelines for In-patient and Residential staff. Staff in Mental Health and Learning Disability In-

Appendix 1 MORTALITY GOVERNANCE POLICY

NHS Grampian. Local Report ~ March Blood Transfusion

Development of an integrated blood shortage plan for the National Blood Service and hospitals

COMPETENCIES FOR HEALTHCARE ASSISTANT IN SEXUAL HEALTH (BAND 3)

Elmarie Swanepoel 24 th September 2017

ADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL

CONTROLLED DOCUMENT. All Managers. All Employees. Page 1 of 30. Health and Safety Policy Issued: 26/01/2017

RESEARCH GOVERNANCE POLICY

Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives

Patient Identification

EQuIPNational Survey Planning Tool NSQHSS and EQuIP Actions 4.

Control of Artificial Optical Radiation at Work Regulations 2010 Contributes to CCQ Core Outcome 4

Student radiographers and trainee assistant practitioners: verifying patient identification. seeking consent. Summary. Acknowledgements.

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case

Need for transfusion? Supply, safety, PBM and consent Katy Cowan - PBM Practitioner

NURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Agenda item 3.3 Appendix 4 MANDATORY TRAINING POLICY

NHS Summary Care Record. Guide for GP Practice Staff

OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1

Transcription:

Blood Transfusion Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Clinical The policy describes the framework and principles required to deliver best transfusion practice. 014 Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: Approved By: Executive Medical Director Chairperson of the Hospital Transfusion Committee Chief Executive On: December 2014 Review Date: Distribution: Essential Reading for: Information for: March 2018 (review date extended) All staff involved in the transfusion process. All staff Page 1 of 14

Contents Paragraph Page 1 Policy Statement 3 2 Scope 3 3 Framework 3 4 Duties 7 5 Implementation and Monitoring 10 6 Associated Policy and Procedural Documentation 10 7 References 11 Appendices Appendix A Monitoring Matrix 12 Appendix B Flowchart of the Transfusion Process showing Roles and Responsibilities 14 Page 2 of 14

1. Policy Statement 1.1 The purpose of this policy and its associated documents is to ensure that all aspects of the transfusion process from blood sampling to the administration of blood is safely delivered within the Trust. This will be achieved by ensuring that: 1.1.1 A holistic approach to the management of a patient at risk of transfusion is adhered to by minimising the need for donor blood without detriment to the clinical outcome; 1.1.2 risks associated with blood transfusion are minimised by reducing unnecessary use of blood components together with the use of correct procedures throughout the transfusion process; 1.1.3 patients are appropriately identified at all relevant stages of the blood transfusion process; 1.1.4 appropriate consent is obtained; and 1.1.5 all current and relevant legislation, regarding blood transfusion, is adhered to. 2. Scope The policy applies to all members of staff including students, locums and agency staff and staff employed on honorary contracts who are involved in the transfusion process in the Trust, on or off the premises. 3. Framework 3.1 This section describes the broad framework for the Blood Transfusion Policy. Detailed instructions are provided in the following associated procedural documents: 3.1.1 Blood Transfusion: Procedure 1 Prescribing and Requesting Blood. 3.1.2 Blood Transfusion: Procedure 2 Patient Identification, sample labelling and sample quality. 3.1.3 Blood Transfusion: Procedure 3 Collection of Blood and Blood Components from blood bank fridges and incubators. 3.1.4 Blood Transfusion: Procedure 4 Blood administration and transfusion reactions. Page 3 of 14

3.1.5 Blood Transfusion: Procedure 5 Massive Haemorrhage Protocol and Urgent Transfusion. 3.1.6 Blood Transfusion: Procedure 7 Refusal of Blood and Blood Components including the care of Jehovah s Witnesses. 3.1.7 Blood Transfusion: Procedure 8 Emergency Blood Management Plan (Procedure 8). 3.2 The Chair of the Hospital Transfusion Committee shall approve all procedural documents associated with this policy, and any amendments to such documents, and is responsible for ensuring that such documents are compliant with this policy. 3.3 All patients that are identified as potentially needing a blood transfusion will be assessed by medical staff or nurses working to expanded practice protocol to authorise blood components. If appropriate, alternatives will be considered as set out in Procedure 7. 3.4 Appendix B provides details of the transfusion process and who is responsible at each stage of it (see section 3.5-3.12 below). 3.5 Informing Patients (see Procedure 1 for full details) 3.5.1 All patients or their representative (if the patient is unconscious, semi conscious or lacks capacity) must be informed where possible that the patient may require a transfusion of blood or blood components in accordance with Procedure 1. 3.6 Consent and Refusal (see Procedure 7 for full details) 3.6.1 Before any blood or blood component is administered appropriate consent should be obtained from the patient in accordance with Procedure 7 and the Procedure for Consent to the Examination or Treatment. 3.6.2 In an emergency situation if a patient refuses to have a blood transfusion the Legal Services Team must be contacted during office hours or the duty Executive for out of hours. 3.6.3 Where the patient refuses to consent to treatment Procedure 7 must be adhered to. Page 4 of 14

3.7 Prescribing and Requesting Blood Components (see Procedure 1 for full details) 3.7.1 The prescribing clinician must prescribe blood in accordance with Procedure 1. 3.7.2 When requesting blood or blood components the appropriate forms and all relevant information must be supplied as set out in Procedure 1. 3.8 Sample Labelling and Quality (see Procedure 2 for full details) 3.8.1 Only staff trained in phlebotomy and authorised to take samples for transfusion purposes can do so and must adhere to the process in Procedure 2. 3.8.2 Whenever a sample is being obtained a positive identification of the patient must be obtained by the staff member carrying out the task in accordance with Procedure 2. 3.9 Blood Bank Cross-match procedure /Issue of Blood Components (see Procedure 1) 3.9.1 The Blood Bank will not accept samples if insufficient patient details are supplied, there is a discrepancy between patient details on the form and on the sample and if tubes are labelled with a patient Identification label. 3.9.2 The Blood Bank is open 24 hours and will provide blood or blood component for when it has been requested providing that 24 hour notice has been provided by the requestor. For emergency requests see 3.12. 3.9.3 Where there are any special requirements or instructions for the ward regarding the administration of blood or blood component the Blood Bank must provide details of this on the Transfusion Record. 3.10 Collection of Blood and Blood Components (see Procedure 3 for full details) 3.10.1 All blood components must be stored and issued in accordance with figure 1 in Procedure 3. Page 5 of 14

3.10.2 Blood is available for use for 24-48 hours after it has been required for a patient. 3.10.3 Blood and blood components that have not been transfused must be returned to the Blood Bank in accordance with Procedure 3. 3.10.4 If the wrong blood has been collected it must be returned to the blood bank immediately and an incident must be reported in accordance with the Trusts Incident Reporting Policy Incidents must also be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) through Serious Adverse Blood Reactions and Events (SABRE). 3.11 Blood Administration (see Procedure 4 for full details) 3.11.1 The Pre-Transfusion process must be followed by relevant staff as set out in Procedure 4. 3.11.2 The transfusion must be commenced within 30 minutes of removal from the fridge and be complete within 4 hours of removal from the fridge. 3.11.3 Used blood bags and transfusion equipment must be safely disposed of in accordance with Procedure 4. 3.11.4 Where the patient experiences minor, severe or serious reactions to the administration of blood or blood components, procedure 4 must be adhered to. 3.11.5 In cases of serious reactions the transfusion must be stopped and must be reported in accordance with the Trust s Incident Reporting Policy This will then be reviewed by the Hospital Transfusion Team and reported to Serious Hazards of Transfusion (SHOT) or Serious Adverse Blood Reactions or Events (SABRE). 3.12 Massive Transfusion for Trauma or Massive Haemorrhage (see Procedure 5 for full details) 3.12.1 Massive Transfusion is defined in Procedure 5. 3.12.2 In the case of a massive transfusion for trauma or massive haemorrhage the patient must be treated as described in Procedure 5. Page 6 of 14

3.12.3 Where a patient is being transferred from one hospital to another the receiving Blood Bank must ensure the blood is safe for use before it is administered by the receiving hospital. 3.13 Training (see Trust Training Catalogue for full details) All those members of staff who are involved in the transfusion process must be appropriately trained as set out in the associated Training Catalogue (Training Needs Analysis). 3.14 Emergency Blood Management (see Procedure 8 for full details) 3.14.1 The Emergency Blood Management Group (EBMG) responds to the national integrated plan for blood shortages. The national plan is structured to provide a framework of actions for the NHS Blood and Transplant (NHSBT) Service and all hospitals in three phases: a) Green: normal circumstances where supply meets demand b) Amber: Reduced availability of blood for a short or prolonged period c) Red: Severe prolonged shortage. 3.14.2 The Trust will initiate the plan in accordance with Procedure 8 3.15 Procurement 4. Duties Clinical Laboratory Services on behalf of the Trust is responsible for the procurement of blood, blood components and named blood products. Such materials will only be procured from organisations that fully comply with the United Kingdom Safety and Quality Regulations 2005 (BSQR 2005). 3.15.1 The provision of blood and associated services between the Trust, its suppliers and users will be subject to a written contract. 3.15.2 Users as Contract Acceptors must also be compliant with BSQR 2005. A detailed description of duties and responsibilities of individuals involved in each step of the process can be found in each specific linked procedure. Page 7 of 14

4.1 Assistant Directors, Divisional Directors, Group Managers, Clinical Service Leads, Associate Directors of Nursing and Matrons Assistant Directors, Divisional Directors, Group Managers, Clinical Service Leads, Associate Directors of Nursing and Matrons are responsible for: 4.1.1 Incorporating the Blood Transfusion Policy and the associated procedures into their working practice; and 4.1.2 Ensuring that staff implement the policy and the associated procedures. 4.2 Hospital Transfusion Committee (HTC) The HTC must ensure that there is a framework that enables the Trust to comply with current legislation and guidance. The framework is set out in this policy and the HTC has the authority to modify and improve existing Blood Transfusion procedures and introduce appropriate changes in practice. 4.3 Hospital Transfusion Team (HTT) The HTT is responsible for implementing the Better Blood Transfusion programme in accordance with Health Service circulars 1998/224, 2002/009 and 2007/001, Patient Blood Management 2014, NHS England, Blood Safety and Quality Regulations 2005 and National Patient Safety Agency circulars involving blood transfusion. This is achieved through policy, review of services, education and audit. The HTT has representation from the laboratories and works closely with the Clinical Laboratory Services. 4.4 Emergency Blood Management Group (EBMG) The EBMG is a sub group of the HTC. It is the responsibility of this group to action and monitor the contingency plan for blood shortages in accordance with Procedure 8. 4.5 All those members of staff who are involved in the transfusion process in the Trust The specific duties of all those involved in the transfusion process are detailed in the associated procedural documents but where appropriate within their roles they are responsible for: Page 8 of 14

4.5.1 Maintaining competence and demonstrating evidence of this at their annual appraisal; 4.5.2 Adhering to Procedures 1-8; 4.5.3 Prescribing appropriately having considered the alternatives to transfusion of a blood component and document the reason for the transfusion and the desired clinical outcome; 4.5.4 Ensuring that the patient receives all relevant information and consents to transfusion and that this is documented; 4.5.5 Ensuring that the patient is correctly identified throughout the transfusion process; 4.5.6 Ensuring that samples are correctly labelled and are not contaminated; 4.5.7 Transporting and delivering blood components, between specified areas under correct storage conditions within a specified timeframe; and 4.5.8 Responsible for the investigation and clinical management of any reaction a patient may have to a transfusion 4.6 Laboratory Staff Laboratory Staff are responsible for: 4.6.1 Maintaining competence in procedures, demonstrating evidence of this and required training and assessment at their annual appraisal; 4.6.2 Responding to requests for blood and blood components in a accordance with Procedure 1; 4.6.3 Alerting clinical staff to any problems; 4.6.4 Highlighting the records of patients needing special requirements on the Blood Bank electronic database; and 4.6.5 Providing the most appropriate component. Page 9 of 14

5. Implementation and Monitoring 5.1 Implementation 5.1.1 This policy will be available on the Trust s Intranet Site. The policy will also be disseminated through the management structure within the Trust. 5.1.2 Implementation of the document is supported through training, linked procedures and the indication for transfusion on the front of each transfusion request form. 5.2 Monitoring Appendix A provides full details on how the policy will be monitored by the Trust. 6. Associated Policy and Procedural Documentation Blood Transfusion: Procedure 1 Prescribing and Requesting Blood and Blood Components (Procedure 1) Blood Transfusion: Procedure 2 Patient Identification, sample labelling and sample quality (Procedure 2) Blood Transfusion: Procedure 3 Collection of Blood and Blood Components from blood bank fridges and incubators (Procedure 3) Blood Transfusion: Procedure 4 Blood administration and transfusion reactions (Procedure 4) Blood Transfusion: Procedure 5 Massive Haemorrhage Protocol and Urgent Transfusion (Procedure 5) Blood Transfusion: Procedure 7 Refusal of Blood and Blood Components including the care of Jehovah s Witnesses (Procedure 7) Blood Transfusion: Procedure 8 Emergency Blood Management Plan (Procedure 8) Expanded Practice Protocol to Enable Haematology Outreach Nurse Specialists (Kay Kendall Leukaemia Fund) to Authorise Blood Component Transfusion Procedure for Consent to Examination or Treatment Page 10 of 14

Training Catalogue (Training Needs Analysis) 7. References Guidelines, directives and legislation contained in these references are incorporated into the document; Department Of Health Better Blood Transfusion- Safe and Appropriate use of Blood, Health Service Circular (HSC 2007/001) http://www.dh.gov.uk/ National Patient Safety Agency (NPSA). 2006. Right patient, right blood Safer Practice Notice 14. London National Patient Safety Agency http://www.npsa.uk/ National Patient Safety Agency 2010. Rapid Response Report. National Patient Safety Agency http://www.npsa.uk/ National Blood Transfusion Committee. NHS England Patient Blood Management. 2014 http://www.transfusionguidelines.org.uk/uk-transfusion-committees/national-bloodtransfusion-committee/patient-blood-management NHS Operational Impact Group. 2005. The Impact of the Blood Safety and Quality Regulations 2005 on Hospital Transfusion Laboratories. The NHS Operational Impact Group (OIG) Report. Joint UKBTS/NIBSC Blood Transfusion Services Professional Advisory Committee http://www.transfusionguidelines.org.uk/ NHS Quality Improvement Scotland. Clinical Standards: Blood Transfusion. September 2006. NHS Quality Improvement Scotland http://www.nhshealthquality.org/ Page 11 of 14

Appendix A Monitoring Matrix MONITORING OF IMPLEMENTATION The decision to transfuse is made following consideration of the potential risks and benefits of, and the alternatives to, transfusion. MONITORING LEAD HTP supported by Clinical Audit Department REPORTED TO PERSON/GROUP HTC MONITORING PROCESS As part of a national audit of patient s notes MONITORING FREQUENCY Every 3 years That all patients have been informed appropriately and verbal consent has been obtained The prescribing and requesting of blood and blood components is done appropriately For urgent transfusion, blood is available within the clinical area within 30mins. Emergency blood management arrangements are established The correct blood has been administered appropriately HTP HTC Audit of patient notes Every 3 years HTP HTC Audit of patient notes Every 3 years Clinical Staff supported by HTT HTC Review of all activations of the Massive Haemorrhage Protocol Chair of EBMG EBMG Review following activation or as directed HTP HTC All incidents reported via The online incident reporting (datix) will be reviewed and will form part of a report to the HTC Quarterly Annual Quarterly The correct blood has been administered appropriately HTP HTC An audit of the patient s records who have received a blood transfusion shall be carried out to ensure that the process in procedure 4 has been followed. Page 12 of 14 Every 2 years

Patients in need of a Massive Transfusion for Trauma or Massive Haemorrhage have received the correct treatment. Blood Bank Manager HTC Each case will be reviewed and any inaccuracies will be reported at the HTC Quarterly Page 13 of 14

Appendix B Activity Flow Chart of the Transfusion Process showing roles and responsibilities Staff involve Patient assessment / decision to transfuse / consideration of appropriate alternatives Medical Staff/ Specialist Nurses working to algorithm Provision of patient information and documentation of verbal consent Medical Staff Registered Nurses/Perfusionists Documentation in patient s case notes of baseline clinical and laboratory data and desired outcome of treatment Completion of request form by medical staff Medical Staff Blood sample taking (phlebotomy) All staff trained in phlebotomy and authorised to take X-match samples Blood Bank X-match procedure / Issue of blood components Blood Bank Bio-Medical Scientists Collection and transportation of blood / blood components from the hospital All staff authorised to collect blood / blood components Administration of blood / blood components Patient observation and monitoring Reporting of any adverse incidents Medical Staff Registered Nurses/Perfusionists Authorised Operating Department Practitioners Medical Staff Registered Nurses/ Perfusionists Operating Department Practitioners Page 14 of 14